“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines...

19
“What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public Involvement Programme, NICE

Transcript of “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines...

Page 1: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

“What’s in it for us?”NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation)

Erin WhittinghamPublic Involvement AdviserPublic Involvement Programme, NICE

Page 2: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

“What’s in it for us?”

• Overview of NICE and developing NICE Guidelines

• Key messages: NICE Guideline on the safe and effective use of medicines (medicines optimisation)

• Questions

Page 3: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.

The role of NICE

• To identify good clinical, public health and social care practice using the best available evidence

• To help resolve uncertainty for the public, patients, service users and professionals

• To reduce variation in the availability and quality of practice and care.

Page 4: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

The Citizens Council:advising on social values

• The Citizens Council is a panel of 30 members of the public that largely reflect the demographic characteristics of the UK.

• The Council considers societal and ethical issues relevant to NICE work. For example:

- Should NICE take age into account?

- Should the NHS pay a premium for treatments for people with rare conditions?

- What aspects of benefit, cost and need should NICE take into account when developing social care guidance?

• Council’s views underpin social value judgements used by NICE committees and other advisory bodies

Page 5: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Core principles of NICE guidance

• Comprehensive evidence base

• Expert input

• Public involvement

• Independent advisory committees

• Genuine consultation

• Regular review

• Open and transparent process

Page 6: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

The importance to users of services and carers• “Confidence in the clinical system”

• “Confidence in staff looking after me”

• “Understand what treatment to expect”

• Better patient experience and outcomes

• Empowers peoples to make choices about their own care

• A constitutional right to receive treatment and medicines.

Page 7: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

The importance for health professionals

• Guides practice

• “Brings together what the research tells us in the context of what is already known”

• “Pragmatic approach to clinical problems seen every day”

• “Helps me to keep my practice up to date”

• Health professionals should take NICE guidance into account when deciding what treatments to give people

Page 8: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Developing NICE Guidelines – involving the public

Referral

Scoping

Development

Consultation

Publication

Implementation support

• Local Healthwatch

• National organisations

• Users of services, families and carers

Page 9: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Patient experience in adult NHS services

Medicines optimisation

Medicines adherence Drug allergy

Overarching NICE guidance

Page 10: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Definition of medicines optimisation

‘a person-centred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes

from their medicines’

Page 11: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

• Accurately listing your medicines

• Sharing information about your medicines

• What should you expect at a medication review?

• Using a self-management plan

• Mistakes with medicines

Page 12: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Identify

Prioritise

Report

Take action

Apply and share learning

What is a ‘Fair Blame’ culture?

Who benefits?

Page 13: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

We are KEY in making decisions about our medicines

“What’s in it for us?”

Page 14: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Emergency

Page 15: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Shared Decision Making… is a

collaborative process that allows patients and their

providers to make health care decisions together, taking into account the best scientific

evidence available, as well as the patient’s values and preferences

Angela Coulter and Alf Collins, The King’s Fund

Page 16: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

• Shared understanding

• Information

• Goals

• Values

• Preferences

“What’s in it for us?”

Page 17: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Could these questions help you?

These questions may help you discuss your condition or the

treatments you have been offered with your care team: • How often should my medicines be reviewed?

• Who sees the information about what medicines I'm taking?

• Will the information about my medicines be kept confidential?

• What are the benefits of using a self‑management plan?

• Can you tell me about using a patient decision aid?

• How do I report a side effect or a bad reaction to a medicine?

• What do I do if I think I no longer need a medicine?

• What do I do if I think a medicine isn't working?

• Who do I speak to if I want to stop taking a medicine?

• What do I do if I think a mistake has been made with my medicines?

Page 18: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

We are KEY in making decisions about our medicines

“What’s in it for us?”

Page 19: “What’s in it for us?” NICE Guideline: Safe and Effective use of Medicines (Medicines Optimisation) Erin Whittingham Public Involvement Adviser Public.

Questions?

[email protected]

Thank you!